Login / Signup

Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis.

Lidia SacchelliA PatriziC LoiF Bardazzi
Published in: Clinical and experimental dermatology (2019)
Keyphrases
  • combination therapy
  • ankylosing spondylitis
  • high intensity
  • coronary artery disease
  • early onset
  • atopic dermatitis
  • rheumatoid arthritis